Tumors escape killing by the immune system through generating transient spatial cell-in-cell structures that are impenetrable to cytotoxic compounds including lytic granules and chemotherapy.
Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy
Posted in biotech/medical